Human nutrition growth offsets a sharp animal nutrition decline
Management linked the quarter's momentum to human nutrition, while animal nutrition volumes fell 52% QoQ and realisation dropped 40% YoY.
Filed 11 Aug 2026, 13:24 IST · FERMENTA (FERMENTA)
Key takeaways
- Human nutrition was the growth engine, with revenue up 24% QoQ to Rs 76.5 cr and volumes rising 18% QoQ.
- Animal nutrition remained the weak link, with volumes down 52% QoQ and average realisation down 40% YoY.
- Consolidated operating margin was 14.82%, while other income of Rs 4.37 cr was a material contributor to pre-tax profit of Rs 14.69 cr.
Human nutrition drove the quarter
The business mix shifted toward human nutrition, where management said revenue rose 24% QoQ to Rs 76.5 cr as segment volumes increased 18% QoQ. That growth contrasted with the sharp contraction in animal nutrition, making the latter the main drag on the quarter's operating picture.
Animal nutrition faced both volume and pricing pressure
Management said animal nutrition volumes fell 52% QoQ and 20% YoY, while average realisation declined 40% YoY. This combination points to pressure from both demand and pricing rather than a single-volume issue. Consolidated operating margin stood at 14.82%, and other income of Rs 4.37 cr provided a meaningful lift alongside pre-tax profit of Rs 14.69 cr.
Initiatives extend beyond the reported quarter
The company said it is conducting Vitamin D awareness campaigns with a global healthcare company. It also said it is supporting the DFQT+ digital traceability solution to improve fortification quality assurance, adding a quality-assurance initiative to its human-nutrition focus.
Q1FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹122 cr |
| Other income | ₹4 cr |
| Expenses | ₹104 cr |
| Operating profit | ₹18 cr |
| Operating margin (%) | 14.82% |
| Interest | ₹3 cr |
| Depreciation | ₹5 cr |
| Profit before tax | ₹15 cr |
| Tax | ₹5 cr |
| Net profit | ₹10 cr |
| EPS (₹) | ₹3.40 |
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
This quarter
- Human nutrition revenue increased 24% QoQ to INR 76.5 crore, with segment volumes up 18% QoQ.
New initiatives
- Fermenta is conducting Vitamin D awareness campaigns with a global healthcare company.
- Fermenta is supporting the DFQT+ digital traceability solution to improve fortification quality assurance.
Problems & risks
- Animal nutrition volumes fell 52% QoQ and 20% YoY, while average realisation declined 40% YoY.
What to watch
- Human nutrition revenue and volumes after reaching Rs 76.5 cr and rising 18% QoQ.
- Whether animal nutrition volumes recover from the 52% QoQ decline.
- Whether operating margin moves from 14.82% as the business mix evolves.